Professional Documents
Culture Documents
Ese Linea Brochure Hepatitis Retrovirus m0870003976 e Low
Ese Linea Brochure Hepatitis Retrovirus m0870003976 e Low
Easy, automated • Accurately differentiate hepatitis and retroviruses infections with the widest
and efficient portfolio of chemiluminescence immunoassays (CLIA)
• Safely select donors with the widest validated panel for screening post-mortem
organs, tissues and cells, including HBV, HCV, HDV, HEV, HIV and HTLV
• Consolidate the fully-automated CLIA hepatitis and retroviruses panel within our
comprehensive portfolio for infectious disease diagnosis
Prevention starts The commitment to stopping new viral hepatitis and retroviruses infections starts with
with diagnosis the accurate and early diagnosis of infected individuals.
DiaSorin improves the prevention and treatment of both epidemics by optimizing first-
line virological evaluation with a complete, fully-automated CLIA diagnostic panel.
The vast selection of high-quality assays are validated for both diagnosis and screening
purposes, and designed for use with the LIAISON® XL high-performance testing system.
Anti-HAV
HAV
HAV IgM
Anti-HBs
Aid diagnosis
HBc IgM
HBeAg
HBV
Anti-HBe
HBsAg Quant
HIV Ab/Ag
HIV
Aid diagnosis
HIV Ab/Ag HT
Blood donor screening
HDV Anti-HDV
Aid diagnosis
Anti-HEV IgM Post-mortem screening
of donor organs,
HEV tissues and cells
Anti-HEV IgG
The DiaSorin DiaSorin’s strong commitment to infectious disease prevention has been serving
advantage laboratories around the world for over 50 years. Today more than ever, you can trust
the automated, high-quality clinical results of our unique immunodiagnostic solution
for hepatitis and retroviruses detection to enhance the efficiency and productivity of
any medical facility.
HR
Ordering Information
Target Kit Code
Diasorin S.p.A
Via Crescentino SNC, 13040 Saluggia (VC) - Italy
www.diasorin.com